This inventor holds 1 USPTO granted patent. Top assignee: Medifron Dbt Inc.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Hye Min Ju: Innovator in O-GlcNAcase Inhibition
Introduction
Hye Min Ju is a notable inventor based in Gunpo, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that have therapeutic potential.
Latest Patents
Hye Min Ju holds a patent for a compound having inhibitory activity against O-GlcNAcase. This invention relates to a novel compound that can inhibit the activity of O-GlcNAcase, which may have implications for various medical applications.
Career Highlights
He is currently associated with Medifron Dbt Inc., where he continues to engage in innovative research and development. His work focuses on creating compounds that can lead to advancements in medical treatments.
Collaborations
Hye Min Ju collaborates with talented individuals in his field, including Hee Kim and Hee Jin Ha, who contribute to his research efforts.
Conclusion
Hye Min Ju's work in developing compounds with inhibitory activity against O-GlcNAcase showcases his commitment to innovation in biochemistry. His contributions are paving the way for future advancements in medical science.